Laffer Tengler Investments Vertex Pharmaceuticals Inc Transaction History
Laffer Tengler Investments
- $509 Billion
- Q4 2024
A detailed history of Laffer Tengler Investments transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Laffer Tengler Investments holds 4,134 shares of VRTX stock, worth $2.03 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
4,134
Previous 2,874
43.84%
Holding current value
$2.03 Million
Previous $1.34 Billion
24.55%
% of portfolio
0.33%
Previous 0.27%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,757Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.9 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.4 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.89 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.13 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...